Intelligent Health AI Conference September 2020 - King's
summary
A London research hub builds AI pipelines and computing platforms for biomarker discovery and population screening, backed by £26 million funding and integrated with imaging ML for MRI and CT and with consumer assays for saliva blood and urine. The consortium spans 4 universities and 11 NHS trusts with access to 25 million patients, runs an accelerator for longevity AI startups, partners with NVIDIA GSK IBM and Unilever, and pilots MVPs with SMEs for prevention and precision diagnostics.
AI-written summary · about
chapters (8)
- 0:00Intro
- 2:21St Thomas' Hospital Campus, King's College London
- 3:39KCL Biomedical Engineering & Imaging Sciences
- 6:13Al-Enabled Hospital Infrastructure
- 6:56Al Informatics Infrastructure
- 7:55Longevity Al Consortium Overview
- 10:12Primary R&D Goals - End-to-End Healthy Longevity Research
- 14:03Al-Driven Development of Biomarker Panels of Aging
